Penetration of vancomycin into human lung tissue

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 5, 1996, Pages 865-869

  Cruciani, M ^a   Gatti, G ^b,d   Lazzarini, L ^a   Furlan, G ^a   Broccali, G ^a,c   Malena, M ^a   Franchini, C ^a   Concia, Ercole ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c B T Biotecnica   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG PARENCHYMA; MALE; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS;

EID: 0029803527     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.5.865     Document Type: Article

References (10)

1. Acar, J. F. & Goldstein, F. W. (1991). Disk susceptibility test. In Antibiotics in Laboratoryn Medicine, 3rd edn (Lorian, V., Ed.), pp. 17-52, Williams & Wilkins, Baltimore, MD.
2. Baldwin, D. R., Honeybourne, D. & Wise, R. (1992a). Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrobial Agents and Chemotherapy 36, 1171-5.
3. Baldwin, D. R., Honeybourne, D. & Wise, R. (1992b). Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrobial Agents and Chemotherapy 36, 1176-80.
4. Geraci, J. E., Heilman, F. R., Nichols, D. R., Wellman, W. E. & Ross, G. T. (1957). Some laboratory and clinical experiences with a new antibiotic, vancomycin. Antibiotics Annual 1956-1957, 91-106.
5. Lamer, C., De Beco, V., Soler, P., Calvat, S., Fagon, J.-Y., Dombret, M.-C. et al. (1993). Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrobial Agents Chemotherapy 37, 281-6.
6. Matzke, G. R. (1992). Vancomycin. In Applied Pharmacokinetics, 3rd edn (Evans, W. E., Shentag, J. J. & Jusko, W. J., Eds), pp. 15.2-15.31. Applied Therapeutics, Vancouver, WA.
7. May, D. G., Stratton, C. W., Denney, W. D., Watts, F. L., Bernard, G. R. & Branch, R. A. (1987). Vancomycin entry into lung lymph in sheep. Antimicrobial Agents and Chemotherapy 31, 1689-91.
8. Plaue, V. R., Bethke, R. O., Fabricius, K. & Muller, O. (1980). Kritische Untersuchungen zur Methodik von Antibiotikaspiegelbestimmungen in menschlichen Geweben. Arzneimittel Forschung Drug Research 30, 1-5.
9. Sun, H., Maderazo, E. G. & Krusell, A. R. (1993). Serum protein-binding characteristics of vancomycin. Antimicrobial Agents Chemotherapy 37, 1132-6.
10. Torres, J. R., Sanders, C. V. & Lewis, A. C. (1979). Vancomycin concentration in human tissues - preliminary Report. Journal of Antimicrobial Chemotherapy 5, 475-7.